The China antibodies market is on a remarkable growth trajectory, currently valued at approximately 12.36 USD and projected to reach an astounding 94.0 USD by 2035, reflecting a compound annual growth rate (CAGR) of 13.72%. This significant market expansion is fueled by the rising demand for advanced therapeutic solutions, spurred by an increasing prevalence of chronic diseases and ongoing...